Vertex Pharmaceuticals revenue reaches $3.44bn as $9bn Crinetics deal cuts profit and raises pipeline stakes
Read More Pharma Industry News FDA grants approval to Yescarta for treatment of certain types of lymphoma In a significant development for lymphoma treatment, Kite Pharma, a subsidiary of Gilead Sciences, has received approval from… bypharmanewsdailyOctober 19, 2017
